The Efficiency of Kamavit®-forte in the Treatment of Erectile Dysfunction and Diseases in Men, Leading to Infertility
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
An erection disorder is the most frequently observed phenomenon in sexual practice, the frequency of which increases with age and is associated with conditions such as partial age related immunodeficiency, diabetes mellitus, depression, atherosclerosis, dyslipidemia, endothelial failure and stress.
The objective: to study the efficiency and safety of Kamavit®-forte in the treatment of erectile dysfunction and male infertility.
Materials and methods. We examined 60 patients aged 23 to 62 years with ED lasting from 1 to 8 years. The study was conducted for 3 months, patients of the main group (MG) took Kamavit®-forte 1 tablet 3 times a day for 90 days.
Results. Before treatment, the testosterone level was 3,1±0,5 ng/ml, after – 6,9±0,3 ng/ml. Thus, after treatment, a significant (p<0,05) increase in blood testosterone levels was observed, which led to the stimulation of sexual function, in particular, libido. Before treatment, libido was retained in 7 (23,3%) patients, and after treatment, in 27 (90%) patients with hypertension. There is a clear tendency to improve an erection according to the subjective assessment of those examined as a result of taking the study drug. So, if before treatment a full erection was in 12 (40%), patients and a partial erection – only in 10 (33,3%), then after a course of taking the drug, a full erection was restored in 23 (76,7%) and in general 29 (96,7%) patients were able to coitus.
Conclusion. The appointment of Kamavit®-forte led to a significant increase in ICEF indicators: achieving an erection – by 89,4%, erection during sexual stimulation – by 68,4%, sufficiency of an erection – by 66,7%; a significant increase in the parameters characterizing the sexual activity of patients: erectile function – by 86%, sexual intercourse – by 84%, orgasm – by 79,4%, libido – by 84,9%. With the use of Kamavit®-forte, an improvement in most spermogram indicators was observed; the volume of ejaculate increased, the concentration of sperm, their total number, motility, the number of live sperm, decreased the number of leukocytes, red blood cells, liquefaction time, the number of pathological forms of sperm.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Еректильна дисфункція: етіологія, патогенез, діагностика та методи лікування / І.І. Горпинченко, А.М. Ситенко // Здоровье мужчины. – 2016. – № 2. – С. 6–8.
Горпинченко И.И. Эректильная дисфункция / И.И. Горпинченко, Я.О. Мирошников // Медицина світу. – 2009. – 85 с.
Горпинченко И.И., Гурженко Ю.Н., Спиридоненко В.В. (2010). Применение экстракта якорцев стелющихся (Трибестан) в терапии хронического простатита и мужского бесплодия (рекомендации для практических врачей). – Киев, 16 с.
Горпинченко И.И. Сексуальные расстройства при неврозах у мужчин / И.И. Горпинченко // Журнал практичного лікаря. – К., 2001. – № 2. – С. 8.
Горпинченко И.И. Эректильная дисфункция: диагностика и современные методы лечения // Здоровье мужчины. – 2002. – № 1. – С. 9–11.
Литвинець Є.А., Зеляк М.В., Томусяк Т.Л. Хронічний простатит: фітотерапія у комплексному лікуванні // Урологія. – 2001. – № 4. – С. 42–43.
Akram M., Asif H.M., Akhtar N. et al. (2011) Tribulus terrestris Linn.: A review article. J. Med. Plants Res., 5(16): 3601–3605.
Althof S.E., Corty E.W., Lewine S.B., et al. EDITS: development of questionaries for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53,4:793-799.
Helmerharst F.M., Finken M.J.J., Erwich J.J. Antisperm antibodies Detection assays for antisperm antibodies: what do they test? // Hum Reprod. – 1999. – Vol. 14. – P. 1669–1671.
Jarow J.P. Endocrine causes of male infertility / J.P. Jarow // Ural. Ctin. N.A. – 2003. – Vol. 30. – P. 640–645.
Rosen R.C., Riley A., Wagner G. et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction // Urology. – 1997. – V. 49. – P. 822–830.
WHO. Мanual for the standardized investigation and diagnosis of the infertile couple. – WHO, 3th ed. Cambridge universiti press, 2000. – 103 р.
